JP2022512796A5 - - Google Patents
Info
- Publication number
- JP2022512796A5 JP2022512796A5 JP2021522350A JP2021522350A JP2022512796A5 JP 2022512796 A5 JP2022512796 A5 JP 2022512796A5 JP 2021522350 A JP2021522350 A JP 2021522350A JP 2021522350 A JP2021522350 A JP 2021522350A JP 2022512796 A5 JP2022512796 A5 JP 2022512796A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024090820A JP2024119889A (ja) | 2018-10-26 | 2024-06-04 | Ｉ型インターフェロンシグネチャー及び使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862751019P | 2018-10-26 | 2018-10-26 | |
| US62/751,019 | 2018-10-26 | ||
| PCT/IB2019/059178 WO2020084591A1 (en) | 2018-10-26 | 2019-10-25 | Type i interferon signatures and methods of use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024090820A Division JP2024119889A (ja) | 2018-10-26 | 2024-06-04 | Ｉ型インターフェロンシグネチャー及び使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022512796A JP2022512796A (ja) | 2022-02-07 |
| JPWO2020084591A5 JPWO2020084591A5 (https=) | 2022-11-01 |
| JP2022512796A5 true JP2022512796A5 (https=) | 2022-11-01 |
Family
ID=70328348
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021522350A Withdrawn JP2022512796A (ja) | 2018-10-26 | 2019-10-25 | Ｉ型インターフェロンシグネチャー及び使用方法 |
| JP2024090820A Pending JP2024119889A (ja) | 2018-10-26 | 2024-06-04 | Ｉ型インターフェロンシグネチャー及び使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024090820A Pending JP2024119889A (ja) | 2018-10-26 | 2024-06-04 | Ｉ型インターフェロンシグネチャー及び使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12009079B2 (https=) |
| EP (1) | EP3873523A4 (https=) |
| JP (2) | JP2022512796A (https=) |
| KR (1) | KR20210084528A (https=) |
| CN (1) | CN113692287A (https=) |
| CA (1) | CA3117102A1 (https=) |
| EA (1) | EA202191133A1 (https=) |
| IL (1) | IL282479A (https=) |
| MA (1) | MA54085A (https=) |
| WO (1) | WO2020084591A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114836534A (zh) * | 2021-06-08 | 2022-08-02 | 中国医学科学院北京协和医院 | Samd9l基因突变作为i型干扰素病诊断的标志物及其应用 |
| EP4587005A1 (en) | 2022-09-14 | 2025-07-23 | Viatris Asia Pacific Pte. Ltd. | Sip 1 receptor modulators for use in the treatment of type 1 ifn mediated diseases |
| WO2024100139A1 (en) * | 2022-11-09 | 2024-05-16 | Merck Patent Gmbh | Use of ifn-i activity as a biomarker for tlr inhibitor treatment |
| KR20250145681A (ko) * | 2023-02-16 | 2025-10-13 | 알루미스 인크. | 피부과 장애를 치료하는 방법 |
| WO2024173764A1 (en) * | 2023-02-16 | 2024-08-22 | Alumis Inc. | Methods of treating hidradenitis suppurativa |
| WO2024201091A1 (en) * | 2023-03-27 | 2024-10-03 | Institut National de la Santé et de la Recherche Médicale | A gene signature for diagnosing stimulator of interferon genes (sting)-associated vasculopathy with onset in infancy (savi) |
| WO2024216160A1 (en) * | 2023-04-14 | 2024-10-17 | Arc Research Institute | Methods and compositions for using peli2 as a biomarker |
| CN117138038A (zh) * | 2023-09-21 | 2023-12-01 | 北京大学 | 一种预防、治疗或缓解椎体后纵韧带骨化症的药物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1904104T1 (sl) * | 2005-07-08 | 2013-12-31 | Biogen Idec Ma Inc. | Protitelesa SP35 in njihova uporaba |
| EP2077858A4 (en) * | 2006-12-06 | 2011-07-20 | Medimmune Llc | INTERFERON ALPHA-INDUCED PHARMACODYNAMIC MARKERS |
| EP2076590A4 (en) * | 2007-05-03 | 2011-06-01 | Medimmune Llc | SELF-IMMUNE DISEASE SELF-ANTIBODY MARKERS |
| US20120035347A1 (en) * | 2009-04-14 | 2012-02-09 | Schering Corporation | Interferon-alfa sensitivity biomarkers |
| US20130261018A1 (en) * | 2010-10-20 | 2013-10-03 | University Of Tennessee Research Foundation | Interferon gene signature and methods of use thereof |
| AU2012249601A1 (en) * | 2011-04-26 | 2013-05-09 | Genentech, Inc. | Compositions and method for treating autoimmune diseases |
| CN103732251A (zh) * | 2011-05-25 | 2014-04-16 | 米迪缪尼有限公司 | 用针对干扰素-α的抗体治疗全身性红斑狼疮、硬皮病以及肌炎的方法 |
| WO2013101771A2 (en) * | 2011-12-30 | 2013-07-04 | Genentech, Inc. | Compositions and method for treating autoimmune diseases |
| AU2013274389A1 (en) * | 2012-06-13 | 2015-01-22 | Astrazeneca Ab | Fixed dosage regimens for anti-type I interferon receptor (IFNAR) antibodies |
| WO2015082716A1 (en) * | 2013-12-06 | 2015-06-11 | Novimmune S.A. | Anti-tlr4 antibodies and methods of use thereof |
| TWI713453B (zh) * | 2014-06-23 | 2020-12-21 | 美商健生生物科技公司 | 干擾素α及ω抗體拮抗劑 |
| US10689703B2 (en) * | 2015-04-27 | 2020-06-23 | National Jewish Health | Methods of identifying and treating subjects having acute respiratory distress syndrome |
| EP3458479B1 (en) * | 2016-06-08 | 2020-11-04 | AbbVie Inc. | Anti-b7-h3 antibodies and antibody drug conjugates |
| JP2022527542A (ja) * | 2019-04-04 | 2022-06-02 | ヤンセン バイオテツク，インコーポレーテツド | 抗ＩＦＮ－α／ω抗体の投与方法 |
-
2019
- 2019-10-25 EA EA202191133A patent/EA202191133A1/ru unknown
- 2019-10-25 JP JP2021522350A patent/JP2022512796A/ja not_active Withdrawn
- 2019-10-25 KR KR1020217015505A patent/KR20210084528A/ko not_active Withdrawn
- 2019-10-25 CA CA3117102A patent/CA3117102A1/en active Pending
- 2019-10-25 CN CN201980086249.XA patent/CN113692287A/zh active Pending
- 2019-10-25 EP EP19874869.1A patent/EP3873523A4/en not_active Withdrawn
- 2019-10-25 WO PCT/IB2019/059178 patent/WO2020084591A1/en not_active Ceased
- 2019-10-25 US US16/663,527 patent/US12009079B2/en active Active
- 2019-10-25 MA MA054085A patent/MA54085A/fr unknown
-
2021
- 2021-04-20 IL IL282479A patent/IL282479A/en unknown
-
2024
- 2024-06-04 JP JP2024090820A patent/JP2024119889A/ja active Pending